Private Equity in Heart Failure Care; Oral PCSK9 Inhibitor Wins; First Robotic TAVR



(MedPage Today) — A study showed that hospitals bought by private equity firms were admitting disproportionately healthier patients with heart failure — whose outcomes did not correspond with their lower risk. (Journal of the American College…



Source link : https://www.medpagetoday.com/cardiology/prevention/115995

Author :

Publish date : 2025-06-10 16:35:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version